Publication: Pathophysiology of als: What and how much do we know? [Als patofi̇zyoloji̇si̇: Neyi̇, ne kadar bi̇li̇yoruz?]
| dc.contributor.authors | Uluç K., Işak B., Tanridaǧ T., Us Ö. | |
| dc.date.accessioned | 2022-03-28T14:55:12Z | |
| dc.date.accessioned | 2026-01-11T11:39:22Z | |
| dc.date.available | 2022-03-28T14:55:12Z | |
| dc.date.issued | 2008 | |
| dc.description.abstract | Amyotrophic lateral sclerosis is a progressive neurodegenerative disorder, primarily involving motor neurons in the cerebral cortex, brainstem and spinal cord. Most cases are sporadic, although 5-10% are familial, with 10-20% being linked to mutations in the enzyme superoxide dismutase-1. The clinical and pathological features of familial and sporadic cases are strikingly similar. In this review, the proposed mechanisms underlying the pathophysiology of ALS are focused with a hypothetical integrative model. | |
| dc.identifier.issn | 10191941 | |
| dc.identifier.uri | https://hdl.handle.net/11424/256224 | |
| dc.language.iso | tur | |
| dc.relation.ispartof | Marmara Medical Journal | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | ALS | |
| dc.subject | Hypothetical integrative model | |
| dc.subject | Pathophysiology | |
| dc.title | Pathophysiology of als: What and how much do we know? [Als patofi̇zyoloji̇si̇: Neyi̇, ne kadar bi̇li̇yoruz?] | |
| dc.type | review | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 111 | |
| oaire.citation.issue | 1 | |
| oaire.citation.startPage | 102 | |
| oaire.citation.title | Marmara Medical Journal | |
| oaire.citation.volume | 21 |
